The chapter discusses the role of the pharmaceutical industry (pharma) in the COVID-19 pandemic, highlighting how pharma benefits from illness and has elaborate strategies to portray diseases as more widespread and serious than they are.
Pharma benefits from illness and has elaborate strategies to portray diseases as more widespread and serious.
Pharma owns molecules, compounds, and technologies, looking for diseases to which these can apply to increase profits.
The industry was obsessed with ensuring the uptake of certain vaccines while demonizing alternative treatments.